Johnson & Johnson (NYSE:JNJ) announced that it appointed Shawn Millerick as president of Vision Care, Americas. Millerick’s appointment went into effect on Nov. 11, 2024. He holds responsibility for defining strategy and driving growth for the company’s Vision Care portfolio in North America and LATAM. That includes the world’s leading contact lens family, Acuvue. Johnson […]
Johnson & Johnson Vision
Johnson & Johnson launches new intraocular lens in EMEA
Johnson & Johnson MedTech announced that its Vision unit made the Tecnis PureSee lens available in the EMEA region. Tecnis PureSee is a purely refractive, presbyopia-correcting intraocular lens (IOL). It features a proprietary design aimed at delivering uninterrupted, high-quality vision. Johnson & Johnson says it offers high best-in-category contrast and low-light performance compared to a […]
Bausch + Lomb makes another eye drop acquisition
Bausch + Lomb (NYSE:BLCO) announced today that an affiliate purchased the Blink product line from Johnson & Johnson Vision. The over-the-counter Blink product line features eye and contact lens drops, marking another eye care acquisition for Bausch + Lomb. Last week, the company acquired eye drops and a delivery system from Novartis in a deal worth up to […]
Johnson & Johnson Vision launches overnight, intraocular lenses
Johnson & Johnson Vision announced today that it launched an expanded range of Acuvue Abiliti overnight lenses, as well as a new intraocular lens. The FDA approved an expanded range of the Acuvue Abiliti overnight therapeutic lenses for myopia (nearsightedness) management. The approval covers lenses up to six diopters, widening the range from the previously approved […]
5 top ophthalmic device innovations you need to know
Innovation finds its way into all areas of medtech, and ophthalmic treatments represent another burgeoning space. It may not be a new wave, but medtech companies continue to improve upon technologies for the human eye. Implants, lenses and more comprise the space’s latest innovations, with a number of companies finding new ways to fix old […]
Report: J&J Vision spending €100 million to expand Irish facility
J&J Vision reportedly plans to invest €100m in the expansion of its Plassey, Limerick, Ireland facility. The Irish Examiner reported last week that the company plans to expand and create 80 new jobs at the location. In March, the company announced a €35 million investment in the same facility. That cash infusion aimed to create […]
Johnson & Johnson Vision launches new contact lenses
Johnson & Johnson Vision announced today that it launched its new Acuvue Oasys Max 1-day contact lenses and multifocal lenses for presbyopia. The lenses feature Johnson & Johnson’s TearStable technology for tear-film stability and locking in moisture. They also offer the OptiBlue light filter for filtering blue-violet to reduce light scatter for visual clarity. Johnson […]
6 drug delivery innovations you need to know
From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops. Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies. More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With some […]
Johnson & Johnson Vision wins Fast Company award for drug-eluting contact lens
Johnson & Johnson Vision announced today that it was named a winner of Fast Company’s 2022 World Changing Ideas Awards. The eye health business arm of Johnson & Johnson (NYSE: JNJ) received the award in the “Wellness” category for its Acuvue Theravision with ketotifen (etafilcon A drug-eluting contact lens with ketotifen). The drug-eluting contact, which provides a new wearing experience […]
J&J is bringing the world’s first drug-eluting contact lens to market
J&J has a potential alternative to eye drops with its drug-eluting Acuvue Theravision contact lens. As far back as the early 1960s, researchers toyed with the idea of delivering medication through contact lenses. Johnson & Johnson Vision (NYSE:JNJ) Director of Clinica Science Dr. Brian Pall told Drug Delivery Business News that patents back then disclosed how a soft […]
FDA approves Johnson & Johnson Vision’s drug-eluting contact lens
Johnson & Johnson Vision announced today that it received FDA approval for its Acuvue Theravision with Ketotifen. The eye health business arm of Johnson & Johnson (NYSE:JNJ) designed Acuvue Theravision with ketotifen (etafilcon A drug-eluting contact lens with ketotifen) to provide a new wearing experience for contact lens wearers who have allergic eye itch for up to 12 […]
